Alebund Pharmaceuticals (Jiangsu) Limited Class H · HKEX:9637

Alebund Pharmaceuticals (Jiangsu) Limited Class H shareholders

Alebund Pharmaceuticals (Jiangsu) Limited Class H on 6ix: holders from US fund reports. Largest: Lazard Emerging Markets Opportunities ETF, Vanguard International Explorer Fund and The Hartford Healthcare Fund. Each with its filing.

HolderShares% of Alebund Pharmaceuticals (Jiangsu) Limited Class HChangeAs of
Lazard Emerging Markets Opportunities ETF313KnewJun 30, 2026
Vanguard International Explorer Fund111KnewJul 31, 2026
The Hartford Healthcare Fund85,600newJul 31, 2026
Vanguard Emerging Markets Select Stock Fund33,600newJul 31, 2026
Nationwide International Small Cap Fund32,500newJul 31, 2026
NYLIM WMC International Research Equity Fund30,000newJul 31, 2026
Hartford Healthcare Hls Fund12,300newJun 30, 2026
Victory Science & Technology Fund1,100newJul 31, 2026

Alebund Pharmaceuticals (Jiangsu) Limited Class H insider trades